Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

15 Nov 2010 07:00

RNS Number : 1383W
Kingspan Group PLC
15 November 2010
 

Kingspan Group Plc

Interim Management Statement

 

15 November 2010

 

Kingspan Group Plc, the leading international provider of low energy building solutions, today issues the following Interim Management Statement for the period from 1 July to 30 September 2010.

 

Group turnover in the 9 months to 30 September was €865mn, up 6% year on year, with third quarter sales up 15% on prior year following a pattern of particularly strong order intake in the second quarter. The performance of the Group's businesses in the UK was solid given the challenging circumstances, and trading in Mainland Europe continued to build upon the improvements earlier in the year. While the North American construction environment remained subdued, Kingspan's Insulated Panel activity continued to grow its position, although office construction predictably weakened further. Ireland remains depressed, and in Australia our businesses have grown significantly throughout the year.

 

By product segment in the third quarter, Insulated Panels performed particularly well in most regions, up 20% year on year. Combined sales in the UK, Ireland and Western Europe grew 16% in quarter three, whilst the medium term project pipeline remained broadly flat through the period, where it had been gradually trending upward over the preceding year. Order intake has however reduced noticeably from the run rate in the second quarter, but was up 3% on prior year in the period. Central & Eastern Europe sales rose 30% in the quarter, and order intake remained encouraging, up 11%. Similarly in North America sales grew by 21%, and intake was up 10% in the period. In recent months, resistance has been experienced in passing through the sizeable steel and chemical cost increases from mid-year, resulting in pressure on margins. This pressure is likely to prevail for the foreseeable future given the expected macro weakness through the turn of the year, which can also be expected to impact on volumes.

 

Insulation Boards performed well in the period, with sales growing by 21% year on year, and up 10% excluding the recent acquisition in Australia. Activity was particularly robust in the UK, and growth was also achieved in the key future markets of Mainland Europe. Despite government incentive programmes being discontinued in Australia, the business in this region grew in the period as high performance insulation gradually builds its presence.

 

Environmental & Renewables sales were up 1% in the period, owing in the main to a subdued performance of solar hot water in Germany.

 

Access Floors sales were down 4% in the period. Whilst margins held up relatively well, volumes slipped further, particularly in North America, and are not expected to bottom out until 2011.

 

As announced on 11 November, the Group has agreed to acquire the European insulation activities of CRH for a consideration of approximately €120mn, which is subject to certain statutory approvals, and expected to complete early in 2011. This transaction bolsters Kingspan's position as the number one provider of non-fibrous insulation throughout Europe, and establishes a much wider platform from which to continue growing market penetration into the future. The acquisition is expected to be earnings neutral in 2011, and earnings enhancing thereafter. The deal will be comfortably funded from the Group's current facilities, still leaving Kingspan conservatively geared.

 

Net debt at the end of October 2010 was approximately €140mn, up marginally from the figure of €135.1 reported at 30 June last. This figure is expected to reduce by up to €10mn by year end. Capital expenditure, mainly of a maintenance nature, will be in the region of €20mn for the year as a whole.

 

Looking ahead, the more positive sentiment evident around mid-year has eased back recently as the many individual national austerity programmes become factored into more tame macro forecasts for the year ahead. That broad cautionary sense has also crept into expectations for the construction environment in many of the Group's markets.

 

Kingspan has made clear progress in the growth of its products' positions in many markets, although this underlying dynamic has been somewhat overshadowed by global weakness in recent years. This traction leaves the Board confident that those foundations will deliver significant growth in the future. More near-term however, the year to date performance coupled with the current order book is likely to deliver a 2010 full year operating profit in the range of €62mn to €65mn, compared to €62.7mn in prior year.

 

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Dermot Mulvihill, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Ed Micheau, Murray Consultants Tel: +353 (0) 1 4980300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBXDBBGGD
Date   Source Headline
6th Jan 20215:12 pmRNSHolding(s) in Company
5th Jan 20214:03 pmRNSHolding(s) in Company
4th Jan 202110:00 amRNSBlock listing Interim Review
4th Jan 20219:00 amRNSTotal Voting Rights
17th Dec 20209:00 amRNSDirectorate Change
1st Dec 20204:12 pmRNSTotal Voting Rights
16th Nov 20207:00 amRNSTrading Statement
2nd Nov 20201:04 pmRNSDirector/PDMR Shareholding
2nd Nov 202012:19 pmRNSTotal Voting Rights
15th Oct 20205:04 pmRNSDirector/PDMR Shareholding
14th Oct 20201:05 pmRNSDirector/PDMR Shareholding
1st Oct 202012:42 pmRNSTotal Voting Rights
29th Sep 20202:32 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSGreen Private Placement
1st Sep 20203:44 pmRNSTotal Voting Rights
24th Aug 20205:34 pmRNSDirector/PDMR Shareholding
24th Aug 20205:27 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSHalf-year Report
1st Jul 20206:17 pmRNSBlock listing Interim Review
1st Jul 202011:27 amRNSTotal Voting Rights
25th Jun 20203:44 pmRNSHolding(s) in Company
17th Jun 20204:51 pmRNSHolding(s) in Company
2nd Jun 20203:00 pmRNSTotal Voting Rights
1st May 20203:20 pmRNSResult of AGM
1st May 20209:45 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSTrading Statement
17th Apr 20204:11 pmRNSHolding(s) in Company
17th Apr 20207:00 amRNSStatement re AGM
14th Apr 202011:41 amRNSHolding(s) in Company
1st Apr 202012:46 pmRNSTotal Voting Rights
30th Mar 202011:37 amRNSHolding(s) in Company
23rd Mar 202011:05 amRNSHolding(s) in Company
19th Mar 202012:00 pmRNSDividend Declaration
18th Mar 20209:15 amRNSHolding(s) in Company
2nd Mar 20202:23 pmRNSTotal Voting Rights
28th Feb 202010:38 amRNSAnnual Financial Report
26th Feb 20204:54 pmRNSDirector/PDMR Shareholding
24th Feb 20205:49 pmRNSHolding(s) in Company
24th Feb 20202:26 pmRNSDirector/PDMR Shareholding
24th Feb 202010:10 amRNSDirector/PDMR Shareholding
21st Feb 20207:00 amRNSFinal Results
20th Jan 20209:50 amRNSHolding(s) in Company
3rd Jan 20205:21 pmRNSHolding(s) in Company
2nd Jan 202011:00 amRNSBlock listing Interim Review
2nd Jan 202010:00 amRNSTotal Voting Rights
17th Dec 201910:45 amRNSDirector/PDMR Shareholding
11th Dec 20195:40 pmRNSDirector/PDMR Shareholding
2nd Dec 20192:58 pmRNSTotal Voting Rights
18th Nov 20197:00 amRNSTrading Update
5th Nov 201912:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.